Trial intelligence / Profile preview

Oral insulin for prevention of type 1 diabetes in at-risk relatives

NCT00419562Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Feb 2007
Primary completion
Dec 2016
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
6
01

Overview

A Phase 3 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2007; status: completed.

02

Drugs

human insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00419562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call